Mary Miller - Sep 26, 2023 Form 3 Insider Report for Acrivon Therapeutics, Inc. (ACRV)

Role
Chief Legal Officer
Signature
/s/ Rasmus Holm-Jorgensen, Attorney-in-Fact
Stock symbol
ACRV
Transactions as of
Sep 26, 2023
Transactions value $
$0
Form type
3
Date filed
9/28/2023, 07:13 PM
Previous filing
Mar 24, 2022
Next filing
Oct 19, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding ACRV Common Stock 40.4K Sep 26, 2023 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding ACRV Stock Option (Right to Buy) Sep 26, 2023 Common Stock 30K $12.50 Direct F2
holding ACRV Stock Option (Right to Buy) Sep 26, 2023 Common Stock 91.2K $12.50 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These shares represent restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's Common Stock. Of these RSUs: (i) 10,015 RSUs vest as to twenty-five percent (25%) on November 14, 2023, and in 12 substantially equal quarterly installments thereafter; and (ii) 30,414 RSUs vest as to twenty-five percent (25%) on October 17, 2023, and in 12 substantially equal quarterly installments thereafter, each subject to the Reporting Person's continuous service through each such vesting date.
F2 Twenty-five percent (25%) of the shares subject to the option shall vest on November 14, 2023, and the remaining shares subject to the option shall vest in 36 substantially equal monthly installments thereafter, in each case subject to the Reporting Person's continuous service through each such vesting date.
F3 Twenty-five percent (25%) of the shares subject to the option shall vest on October 17, 2023, and the remaining shares subject to the option shall vest in 36 substantially equal monthly installments thereafter, in each case subject to the Reporting Person's continuous service through each such vesting date.

Remarks:

Exhibit List: Exhibit 24 - Power of Attorney